Britain's GSK said on Monday it signed a deal with Hong Kong-listed Sino Biopharmaceutical to expand its presence in the ...

GSK (GSK) reported better-than-expected financials for Q1 2026 on Wednesday as sales from its HIV and cancer medicines offset a sales decline for its general medicines, including its respiratory ...

In GSK’s first quarter under Luke Miels as CEO, the company’s flagship shingles vaccine, Shingrix, set a new quarterly sales record, while its closely watched asthma launch, Exdensur, showed “early ...

Britain's largest drugmakers saw 2026 get off on a positive note, with AstraZeneca and GSK both reporting core earnings ahead of expectations on Wednesday AstraZeneca CEO Pascal Soriot said that if ...

GSK GSK1.32%increase; green up pointing triangle reported higher earnings on increased specialty medicine sales and said it expects to pay a total dividend this year of 70 pence a share. The FTSE ...

When it comes to GSK’s new dealmaking strategy of trying to outdo established blockbusters, CEO Luke Miels has told Fierce that oncology may offer the most tempting targets. Miels—who served as GSK’s ...

LONDON, April 29 (Reuters) - Strong first-quarter results under new GSK (GSK.L), opens new tab CEO Luke Miels on Wednesday failed to impress investors, who raised concerns ‌that the British ...

GSK delivered Q1 core earnings of 46.5p per share, surpassing the 43.5p consensus forecast Approximately 50% of the profit outperformance stemmed from legal settlement adjustments rather than ...

Marketecture Media, a publishing and live event outfit that focuses on the nexus of media and technology, has recruited Jackelyn Keller to serve as chief commercial officer as the company looks to ...